On March 22, 2016, Loews Corporation (the Company) completed
a public offering of $500,000,000 aggregate principal amount of its 3.75% Senior Notes due 2026 (the Notes).
The offering of
the Notes was made pursuant to the Companys shelf registration statement on Form S-3 (Registration No. 333-202247) filed with the Securities and Exchange Commission (the SEC) on February 24, 2015, including a related prospectus and
prospectus supplement dated February 24, 2015 and March 17, 2016, respectively, and filed with the SEC.
In connection with the offering
of the Notes, the Company entered into an Underwriting Agreement, dated March 17, 2016 (the Underwriting Agreement), among the Company and Barclays Capital Inc. and J.P. Morgan Securities LLC, as representatives of the several
underwriters named therein (collectively, the Underwriters).
The Notes were issued under an Indenture, dated as of March 1,
1986, as supplemented by a supplemental indenture, dated March 30, 1993, and a supplemental indenture, dated February 18, 1997 (as so supplemented the Indenture), between the Company and The Bank of New York Mellon, as successor trustee
to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank (National Association)).
Interest will be paid on the Notes semi-annually
on April 1 and October 1 of each year, commencing October 1, 2016, at a rate of 3.75% per annum until April 1, 2026. The Company may redeem the Notes, in whole or in part, at any time prior to January 1, 2026 at a make-whole
redemption price discounted to the redemption date at the rate of U.S. Treasury plus 30 basis points, plus accrued interest to the redemption date. If the Notes are redeemed, in whole or in part, on or after January 1, 2026, the Company will pay a
redemption price equal to 100% of the principal amount of the Notes redeemed, plus accrued interest to the redemption date.
The
Underwriting Agreement, the Indenture and amendments thereto, and the form of the global note for the offering, are filed as exhibits to, or are incorporated by reference in, this Form 8-K, and are incorporated into this Item 8.01 by reference.